{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:53:36Z","timestamp":1792788816759,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Project of Bishan District, China","award":["BSKJ2023019"],"award-info":[{"award-number":["BSKJ2023019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00228-024-03784-5","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:38:05Z","timestamp":1732937885000},"page":"237-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Advances in the study of nebulized tranexamic acid for pulmonary hemorrhage"],"prefix":"10.1007","volume":"81","author":[{"given":"Ping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoni","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"3784_CR1","volume-title":"Pulmonary hemorrhage [M]","author":"B Shee","year":"2024","unstructured":"Shee B, Anjum F, Sharma S et al (2024) Pulmonary hemorrhage [M]. StatPearls Publishing, StatPearls"},{"issue":"Suppl 10","key":"3784_CR2","doi-asserted-by":"publisher","first-page":"S1069","DOI":"10.21037\/jtd.2017.06.41","volume":"9","author":"C Radchenko","year":"2017","unstructured":"Radchenko C, Alraiyes AH, Shojaee S (2017) A systematic approach to the management of massive hemoptysis. J Thorac Dis 9(Suppl 10):S1069\u2013S1086","journal-title":"J Thorac Dis"},{"issue":"9","key":"3784_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40261-020-00946-y","volume":"40","author":"Y-S Tsai","year":"2020","unstructured":"Tsai Y-S, Hsu L-W, Wu M-S et al (2020) Effects of tranexamic acid on hemoptysis: a systematic review and meta -analysis of randomized controlled trials. Clin Drug Investig 40(9):789\u2013797","journal-title":"Clin Drug Investig"},{"issue":"8","key":"3784_CR4","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.21037\/jtd-19-3991","volume":"13","author":"AV Charya","year":"2021","unstructured":"Charya AV, Holden VK, Pickering EMJJOTD (2021) Management of life-threatening hemoptysis in the ICU. J Thorac Dis 13(8):5139","journal-title":"J Thorac Dis"},{"key":"3784_CR5","doi-asserted-by":"crossref","unstructured":"Ker K, Beecher D, Roberts I (2013) Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev 23(7):CD010562","DOI":"10.1002\/14651858.CD010562"},{"issue":"3","key":"3784_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/SHK.0000000000001389","volume":"53","author":"R Stansfield","year":"2020","unstructured":"Stansfield R, Morris D, Jesulola EJS (2020) The use of tranexamic acid (TXA) for the management of hemorrhage in trauma patients in the prehospital environment: literature review and descriptive analysis of principal themes. Shock 53(3):277\u2013283","journal-title":"Shock"},{"issue":"4","key":"3784_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","volume":"47","author":"W Ng","year":"2015","unstructured":"Ng W, Jerath A, W\u0105sowicz M (2015) Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther 47(4):339\u2013350","journal-title":"Anaesthesiol Intensive Ther"},{"key":"3784_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejpb.2015.04.015","volume":"93","author":"M Haghi","year":"2015","unstructured":"Haghi M, Van Den Oetelaar W, Moir LM et al (2015) Inhalable tranexamic acid for haemoptysis treatment. Eur J Pharm Biopharm 93:311\u2013319","journal-title":"Eur J Pharm Biopharm"},{"key":"3784_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pupt.2016.07.006","volume":"40","author":"BL Bellam","year":"2016","unstructured":"Bellam BL, Dhibar DP, Suri V et al (2016) Efficacy of tranexamic acid in haemoptysis: a randomized, controlled pilot study. Pulm Pharmacol Ther 40:80\u201383","journal-title":"Pulm Pharmacol Ther"},{"key":"3784_CR10","doi-asserted-by":"crossref","unstructured":"Prutsky G, Domecq JP, Salazar CA et al (2016) Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst Rev 2;11(11):CD008711","DOI":"10.1002\/14651858.CD008711.pub3"},{"key":"3784_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-019-2620-5","volume":"23","author":"T Kinoshita","year":"2019","unstructured":"Kinoshita T, Ohbe H, Matsui H et al (2019) Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study [J]. Crit Care 23:1\u201310","journal-title":"Crit Care"},{"key":"3784_CR12","doi-asserted-by":"crossref","unstructured":"Mazi A (2022) Tranexamic Acid Use for Massive Hemoptysis in a Child: A Case Report. Cureus 19;14(8):e28186","DOI":"10.7759\/cureus.28186"},{"issue":"6","key":"3784_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/icvts\/ivt383","volume":"17","author":"CA Moen","year":"2013","unstructured":"Moen CA, Burrell A, Dunning JJIC et al (2013) Does tranexamic acid stop haemoptysis? Interact Cardiovasc Thorac Surg 17(6):991\u2013994","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"6","key":"3784_CR14","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","volume":"154","author":"O Wand","year":"2018","unstructured":"Wand O, Guber E, Guber A et al (2018) Inhaled tranexamic acid for hemoptysis treatment: a randomized control led trial. Chest 154(6):1379\u20131384","journal-title":"Chest"},{"issue":"2","key":"3784_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.chest.2015.10.016","volume":"149","author":"G Segrelles Calvo","year":"2016","unstructured":"Segrelles Calvo G, De Granda-Orive I, L\u00f3pez PD (2016) Inhaled tranexamic acid as an alternative for hemoptysis treatment. Chest 149(2):604","journal-title":"Chest"},{"issue":"12","key":"3784_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/01.ccm.0000510560.32498.25","volume":"44","author":"M Patel","year":"2016","unstructured":"Patel M, Abbas F, Sheppard TJCCM (2016) 1887: hemoptysis controlled with the use of inhaled tranexamic acid: a case series. Crit Care Med 44(12):547","journal-title":"Crit Care Med"},{"issue":"12","key":"3784_CR17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1089\/jpm.2015.0167","volume":"18","author":"MJ Hankerson","year":"2015","unstructured":"Hankerson MJ, Raffetto B, Mallon WK et al (2015) Nebulized tranexamic acid as a noninvasive therapy for cancer-related hemoptysis. J Palliat Med 18(12):1060\u20131062","journal-title":"J Palliat Med"},{"issue":"8","key":"3784_CR18","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.rmed.2009.02.004","volume":"103","author":"A Solomonov","year":"2009","unstructured":"Solomonov A, Fruchter O, Zuckerman T et al (2009) Pulmonary hemorrhage: a novel mode of therapy. Respir Med 103(8):1196\u20131200","journal-title":"Respir Med"},{"issue":"5","key":"3784_CR19","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.chest.2022.11.021","volume":"163","author":"B Gopinath","year":"2023","unstructured":"Gopinath B, Mishra PR, Aggarwal P et al (2023) Nebulized vs IV tranexamic acid for hemoptysis: a pilot randomized con trolled trial. Chest 163(5):1176\u20131184","journal-title":"Chest"},{"issue":"8","key":"3784_CR20","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001604","volume":"16","author":"S Patel","year":"2022","unstructured":"Patel S, Angelidis IK, Malsin ES et al (2022) Inhaled tranexamic acid for the management of hemoptysis in a patient with right and left ventricular assist devices: a case report. A A Pract 16(8):e01604","journal-title":"A A Pract"},{"issue":"6","key":"3784_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.amjms.2022.06.018","volume":"364","author":"AH Jafry","year":"2022","unstructured":"Jafry AH, Raza SM, Bajwa A et al (2022) Pulmonary hemorrhage after cardiac resynchronization therapy device implantation - a systematic review. Am J Med Sci 364(6):796\u2013802","journal-title":"Am J Med Sci"},{"issue":"4","key":"3784_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5811\/cpcem.2020.7.48525","volume":"4","author":"JM Dempsey","year":"2020","unstructured":"Dempsey JM, Jones M, Bronner J et al (2020) Inhaled tranexamic acid for massive hemoptysis in the setting of oral anticoagulation: a case report. Clin Pract Cases Emerg Med 4(4):572\u2013575","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"5","key":"3784_CR23","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.jemermed.2018.01.029","volume":"54","author":"S Komura","year":"2018","unstructured":"Komura S, Rodriguez RM, Peabody CR (2018) Hemoptysis? Try inhaled tranexamic acid. J Emerg Med 54(5):e97\u2013e99","journal-title":"J Emerg Med"},{"key":"3784_CR24","doi-asserted-by":"crossref","unstructured":"Sanghvi S, Van Tuyl A, Greenstein J et al (2019) Tranexamic acid for treatment of pulmonary hemorrhage after tissue plasminogen activator administration for intubated patient. Am J Emerg Med 37(8):1602.e5-.e6.s","DOI":"10.1016\/j.ajem.2019.05.024"},{"issue":"1","key":"3784_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jcpt.13463","volume":"47","author":"MG Cabanilla","year":"2022","unstructured":"Cabanilla MG, Villalobos NE, Ahmed S (2022) A role for nebulized tranexamic acid in veno-venous ECMO patients. J Clin Pharm Ther 47(1):125\u2013128","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"3784_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12245-020-00304-x","volume":"13","author":"F Alabdrabalnabi","year":"2020","unstructured":"Alabdrabalnabi F, Alshahrani M, Ismail N (2020) Nebulized tranexamic acid for recurring hemoptysis in critically ill p atients: case series. Int J Emerg Med 13(1):45","journal-title":"Int J Emerg Med"},{"issue":"3","key":"3784_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5144\/0256-4947.2015.231","volume":"35","author":"H Bafaqih","year":"2015","unstructured":"Bafaqih H, Chehab M, Almohaimeed S et al (2015) Pilot trial of a novel two-step therapy protocol using nebulized trane xamic acid and recombinant factor VIIa in children with intractable di ffuse alveolar hemorrhage. Ann Saudi Med 35(3):231\u2013239","journal-title":"Ann Saudi Med"},{"key":"3784_CR28","doi-asserted-by":"crossref","unstructured":"O'neil E R, Schmees L R, Resendiz K et al (2020) Inhaled tranexamic acid as a novel treatment for pulmonary hemorrhage in critically Ill pediatric patients: an observational study. Crit Care Explor 2(1): e0075","DOI":"10.1097\/CCE.0000000000000075"},{"issue":"9","key":"3784_CR29","volume":"14","author":"DM Cutshall","year":"2022","unstructured":"Cutshall DM, Inman BL, Myers M (2022) Treatment of massive hemoptysis with repeated doses of nebulized tranexamic acid. Cureus 14(9):e29625","journal-title":"Cureus"},{"issue":"1","key":"3784_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/jamp.2019.1534","volume":"33","author":"JA Dhanani","year":"2020","unstructured":"Dhanani JA, Roberts J, Reade MC (2020) Nebulized tranexamic acid therapy for hemoptysis associated with submassive pulmonary embolism. J Aerosol Med Pulm Drug Deliv 33(1):12\u201314","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"3784_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Dela Cruz CS (2020) Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41(1):1\u201324","journal-title":"Clin Chest Med"},{"key":"3784_CR32","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 71(3): 209\u201349","DOI":"10.3322\/caac.21660"},{"issue":"3","key":"3784_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","volume":"103","author":"F Nasim","year":"2019","unstructured":"Nasim F, Sabath BF, Eapen GA (2019) Lung Cancer. Med Clin North Am 103(3):463\u2013473","journal-title":"Med Clin North Am"},{"issue":"4","key":"3784_CR34","first-page":"243","volume":"91","author":"JS Earwood","year":"2015","unstructured":"Earwood JS, Thompson TD (2015) Hemoptysis: evaluation and management. Am Fam Physician 91(4):243\u2013249","journal-title":"Am Fam Physician"},{"issue":"24","key":"3784_CR35","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.09.1085","volume":"70","author":"GF Tomaselli","year":"2017","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A et al (2017) 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 70(24):3042\u20133067","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3784_CR36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.25475","volume":"94","author":"A Cuker","year":"2019","unstructured":"Cuker A, Burnett A, Triller D et al (2019) Reversal of direct oral anticoagulants: guidance from the Anticoagulat ion Forum. Am J Hematol 94(6):697\u2013709","journal-title":"Am J Hematol"},{"issue":"21","key":"3784_CR37","first-page":"371","volume":"114","author":"H Ittrich","year":"2017","unstructured":"Ittrich H, Bockhorn M, Klose H et al (2017) The diagnosis and treatment of hemoptysis [J]. Dtsch Arztebl Int 114(21):371\u2013381","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"3784_CR38","first-page":"129","volume":"42","author":"MS Fekri","year":"2017","unstructured":"Fekri MS, Hashemi-Bajgani SM, Shafahi A et al (2017) Comparing adrenaline with tranexamic acid to control acute endobronchial bleeding: a randomized controlled trial. Iranian J Med Sci 42(2):129\u2013135","journal-title":"Iranian J Med Sci"},{"key":"3784_CR39","doi-asserted-by":"crossref","unstructured":"M\u00e1rquez-Mart\u00edn E, Vergara D G, Mart\u00edn-Juan J et al (2010) Endobronchial administration of tranexamic acid for controlling pulmonary bleeding: a pilot study.\u00a0Bronchology Interv Pulmonol\u00a017(2): 122-5.","DOI":"10.1097\/LBR.0b013e3181dc8c17"},{"issue":"4","key":"3784_CR40","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.chest.2022.10.013","volume":"163","author":"S Badovinac","year":"2023","unstructured":"Badovinac S, Glodi\u0107 G, Sabol I et al (2023) Tranexamic acid vs\u00a0adrenaline for controlling iatrogenic bleeding during flexible bronchoscopy: a double-blind randomized controlled trial [J]. Chest 163(4):985\u2013993","journal-title":"Chest"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03784-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03784-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03784-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T08:07:19Z","timestamp":1736410039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03784-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3784"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03784-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}